Straightline Group LLC Amneal Pharmaceuticals, Inc. Transaction History
Straightline Group LLC
- $153 Billion
- Q4 2024
A detailed history of Straightline Group LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Straightline Group LLC holds 11,600 shares of AMRX stock, worth $89,668. This represents 0.06% of its overall portfolio holdings.
Number of Shares
11,600Holding current value
$89,668% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
204Shares Held
121MCall Options Held
121KPut Options Held
84.6K-
Vanguard Group Inc Valley Forge, PA14.8MShares$115 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$95.3 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$87.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$82.9 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$69.4 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.17B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...